Form 4: Moderna Director Sandra Horning Reports Stock Transactions

Director Sandra Horning reports acquisition and disposal of Moderna (MRNA) stock and restricted stock units on April 30, 2025.

Summary

• Sandra Horning, a director at Moderna, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On April 30, 2025, Horning acquired 2,352 shares of common stock.
• On the same date, 979 restricted stock units converted into common stock.
• Horning also acquired 16,233 restricted stock units that will vest on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to continued service.
• Following these transactions, Horning directly owns 16,233 derivative securities.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, so the sentiment is neutral.

Future Outlook

The vesting of restricted stock units is contingent upon the recipient's continued service with Moderna.

Industry Context

Form 4 filings are standard practice for corporate insiders to report transactions in their company's stock, providing transparency to investors.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.

Key Dates

Keywords

Form 4, Beneficial Ownership, Sandra Horning, Moderna, MRNA, Stock Transactions, Restricted Stock Units, Director